
---
title: '呼吸道合胞病毒疫苗和单抗最新研究进展（7）'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951381'
author: 科学网
comments: false
date: Wed, 24 Aug 2022 12:04:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951381'
---

<div>   
<h1 style="margin: 0px; padding: 0px; line-height: normal;"><strong style="font-size: 16px;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 35px;background: #FFFFFF">呼吸道合</span></strong><strong style="font-size: 16px;"><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 35px;background: #FFFFFF">胞病毒预防制剂曙光在前:　</span></strong><br></h1><p style="margin: 45px 0px 69px; padding: 0px; line-height: normal;"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 35px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">疫苗和单克隆抗体百舸争流</span></span></strong></p><p style="margin: 45px 0px 69px; padding: 0px; line-height: normal;"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">前言：</span></span></strong></p><p style="margin: 45px 0px 69px; padding: 0px; line-height: normal;"><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF">　　新冠病毒大流行的将近３年，也是世界疫苗行业突飞猛进、疫苗研发技术日新月异、硕果累累的３年。疫苗制备的多种技术途径都得到深度开发，若干种新兴的技术途径如mRNA疫苗获得了空前的成功，在世界各地大行其道，在多种传染病以及癌症和其他慢性病的防治领域都在不断开花结果。</span></strong></p><p style="margin-top:45px;margin-right:0;margin-bottom:69px;margin-left:0;text-indent:48px;padding:0 0 0 0 "><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">呼吸道合胞病毒（</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px;background: #FFFFFF">Respiratory syncytial virus，</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 1px;font-size: 24px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">）</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">是一种历史悠久、危害极大的传染病，其疫苗的研发已经有四十年的历史，</span><span style="font-family:Microsoft YaHei UI"> 但最初开发的疫苗反而会引发</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疫苗相关性呼吸道疾病（</span><span style="font-family:Microsoft YaHei UI">VAERD，Vaccine-associated enhanced respiratory diseases）</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">，即未接触过</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的儿童在接种了疫苗后，如果再接触到该病毒反而会发生更严重的</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">疾病。诸如此类的问题导致针对</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的疫苗一直未能上市。乘新冠病毒疫苗大跃进的东风，已赚得盆满钵满的疫苗巨头如辉瑞（</span><span style="font-family:Microsoft YaHei UI">Pfizer)、莫德纳（Moderna）和葛兰素史克(GSK)等目前都在</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">RSV</span></span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:Microsoft YaHei UI">的疫苗开发上快马加鞭，有望在较短时间内取得重大突破。</span></span></strong></p><p style="margin-top:30px;margin-right:0;margin-bottom:54px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><strong>　　　　</strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #333333;letter-spacing: 0;font-size: 24px">RSV</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">疫苗和单克隆抗体研究领域来自世界各地的顶级研究人员（约５０人）近期联名在国际著名专业杂志《</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #FF0000;letter-spacing: 0;font-size: 24px">Lancet</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px"> Infect Dis》上发表综述论文，介绍相关最新研究进展（见</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #222222;letter-spacing: 0;font-size: 24px">参考文献</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';color: #069A2E;letter-spacing: 0;font-size: 24px">），本博客将分数次介绍此综述的主要内容。</span></strong></p><p style="margin: 30px 0px 54px; text-indent: 0px; padding: 0px; background: rgb(255, 255, 255); line-height: normal;"><strong><span style="font-family: Calibri;font-size: 29px"><span style="font-family:SimSun">目录：</span></span></strong></p><p style="margin: 30px 0px 54px; text-indent: 0px; padding: 0px; background: rgb(255, 255, 255); line-height: normal;"><strong><span style="font-family: Calibri;font-size: 29px"><span style="font-family:SimSun">摘要</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">一</span>.<span style="font-family:SimSun">　前言</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">二</span>.<span style="font-family:SimSun">　方法</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">三</span>.<span style="font-family:SimSun">　教训（</span><span style="font-family:Calibri">Lessons learned</span><span style="font-family:SimSun">）</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">四</span>.<span style="font-family:SimSun">　减毒活疫苗（</span><span style="font-family:Calibri">live attenuated vaccines</span><span style="font-family:SimSun">，</span><span style="font-family:Calibri">LAVs </span><span style="font-family:SimSun">）</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">五</span>.<span style="font-family:SimSun">　嵌合疫苗（</span><span style="font-family:Calibri">Chimeric </span><span style="font-family:SimSun">）</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">六</span>.<span style="font-family:SimSun">　亚单位疫苗（</span><span style="font-family:Calibri">Subunit</span><span style="font-family:SimSun">）</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">七</span>.<span style="font-family:SimSun">　基于颗粒的疫苗（</span><span style="font-family:Calibri">Particle-based </span><span style="font-family:SimSun">）</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">八</span>.<span style="font-family:SimSun">　核酸疫苗（</span><span style="font-family:Calibri">Nucleic acid</span><span style="font-family:SimSun">）</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">九</span>.<span style="font-family:SimSun">　重组载体疫苗（</span><span style="font-family:Calibri">Recombinant vectors</span><span style="font-family:SimSun">）</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">十</span>.<span style="font-family:SimSun">　单克隆抗体（</span><span style="font-family:Calibri">MAbs</span><span style="font-family:SimSun">）</span></span></strong></p><p style="line-height: normal;"><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"><span style="font-family:SimSun">十一</span>.<span style="font-family:SimSun">　讨论</span></span></strong><strong><span style="font-family: Calibri;line-height: 200%;font-size: 29px"> </span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 32px"><span style="font-family:SimSun">图</span><span style="font-family:Calibri">2:</span><span style="font-family:SimSun">　按预防途径对候选疫苗和单抗的分类　</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">　　<span style="font-family:Calibri">Pre-F</span><span style="font-family:SimSun">蛋白示意图依据蛋白</span></span></strong><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:SimSun">质资料库</span> <span style="font-family:Calibri">RCSB PDB 4MMU </span><span style="font-family:SimSun">生成，</span><span style="font-family:Calibri">post-F</span><span style="font-family:SimSun">蛋白示意图依据资料库</span><span style="font-family:Calibri">3RRT</span><span style="font-family:SimSun">生成。浅灰色表示疫苗开发已终止或暂停。</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">　　简称：</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">RSV =</span><span style="font-family:SimSun">呼吸道合胞病毒。</span><span style="font-family:Calibri">Pre-F=</span><span style="font-family:SimSun">前融合蛋白（</span><span style="font-family:Calibri">prefusion protein</span><span style="font-family:SimSun">）。</span><span style="font-family:Calibri">Post</span></span><span style=";font-family:Calibri;line-height:200%;font-size:21px"> </span><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">F =</span><span style="font-family:SimSun">后融合蛋白（</span><span style="font-family:Calibri">postfusion protein</span><span style="font-family:SimSun">）。</span><span style="font-family:Calibri">Ad=</span><span style="font-family:SimSun">腺病毒。</span><span style="font-family:Calibri">MVA=</span><span style="font-family:SimSun">改良的安卡拉痘苗病毒。</span><span style="font-family:Calibri">BCG =</span><span style="font-family:SimSun">牛结核分枝杆菌。</span><span style="font-family:Calibri">SeV=</span><span style="font-family:SimSun">仙台病毒（</span><span style="font-family:Calibri">sendai virus</span><span style="font-family:SimSun">）。</span></span><span style="font-family: Calibri; font-size: 21px;"> </span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:Calibri;line-height:200%;font-size:21px"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951381" title alt="image.png" width="778" height="509" style="width: 778px; height: 509px;" referrerpolicy="no-referrer"></span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 24px">　　图例：</span></strong><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951378" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">Fusion protein (F) </span>融合蛋白</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951379" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">Glycoprotein (G)</span>糖蛋白　</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951380" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"> <span style="font-family:Calibri">Small hydrophobic protein (SH)</span>小疏水蛋白　</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951382" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">Nucleoprotein (N)</span>核蛋白　</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951383" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">Large polymerase</span>　<span style="font-family:Calibri">protein (L)</span>大多聚酶蛋白　</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951386" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">Nonstructural protein</span>　<span style="font-family:Calibri">(NS)</span>非结构蛋白　</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951387" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">M2-1</span>膜蛋白　 </span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951388" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">M2 </span>　</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951389" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">M2-2 </span>　</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951390" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">Deletion</span>删除　</span><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951391" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:Calibri">Alteration </span>替换</span><span style="font-family: SimSun; font-size: 21px;"> </span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px"><span style="font-family:Calibri">Subunit </span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">亚单位疫苗</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RSVPreF3</span>　<span style="font-family:Calibri">Phase 3 (O)</span><span style="font-family:SimSun">　（</span><span style="font-family:Calibri">3</span><span style="font-family:SimSun">期临床试验）</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RSVPreF3</span>　<span style="font-family:Calibri">Phase 3 (M)</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">DS-Cav1</span>　<span style="font-family:Calibri">Phase 1 (M/O)</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RSVPreF</span>　<span style="font-family:Calibri">Phase 3 (M/O)</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">BARS13</span>　<span style="font-family:Calibri">Phase 2 (P/O)</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">DPX-RSV</span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">VN-0200</span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px"><span style="font-family:Calibri">Immunoprophylaxis</span><span style="font-family:SimSun">免疫预防制剂（</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">单克隆抗体</span></span></strong><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:SimSun">）</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">Nirsevimab</span>　<span style="font-family:Calibri">(Site Ø)</span>　<span style="font-family:Calibri">Phase 3</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RSM01</span>　<span style="font-family:Calibri">(Site Ø)</span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">Narsyn</span>　<span style="font-family:Calibri">Phase 2</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">Clesrovimab</span>　<span style="font-family:Calibri">(Site IV)</span>　<span style="font-family:Calibri">Phase 3</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">Suptavumab</span>　<span style="font-family:Calibri">(Site V)</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">PreF=</span><span style="font-family:SimSun">前融合蛋白（</span><span style="font-family:Calibri">prefusion protein)</span><span style="font-family:SimSun">示意图</span></span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">PostF =</span><span style="font-family:SimSun">后融合蛋白</span></span><span style=";font-family:Calibri;line-height:200%;font-size:21px">(Post</span><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">fusion protein</span></span><span style=";font-family:Calibri;line-height:200%;font-size:21px">)示意图</span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px"><span style="font-family:Calibri">Recombinant vectors</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">重组载体疫苗</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">VXA-RSVf</span>　<span style="font-family:Calibri">ChAd155.RSV</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">MVA-BN-RSV</span>　<span style="font-family:Calibri">Phase 3</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">Ad26.RSV.preF</span>　<span style="font-family:Calibri">Phase 2/3 (P/O)</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px"><span style="font-family:Calibri">Chimeric</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">嵌合疫苗</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">rBCG-N-hRSV</span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">SeV/RSV</span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px"><span style="font-family:Calibri">Live attenuated</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">减</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">毒活疫苗</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RSV-MinL4.0 </span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">IT-RSV-</span><span style="font-family:SimSun">Δ</span><span style="font-family:Calibri">G </span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">VAD0001</span>　 <span style="font-family:Calibri">Phase 1/2</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">LID/</span><span style="font-family:SimSun">Δ</span><span style="font-family:Calibri">M2-2/1030s </span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">MV-012-968</span>　 <span style="font-family:Calibri">Phase 2</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">6120/</span><span style="font-family:SimSun">Δ</span><span style="font-family:Calibri">NS1 </span>　　<span style="font-family:Calibri">Phase</span>　</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">1</span></span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">6120/F1/G2/</span><span style="font-family:SimSun">Δ</span><span style="font-family:Calibri">NS1</span>　<span style="font-family:Calibri">Phase</span>　</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">1</span></span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">6120/</span><span style="font-family:SimSun">Δ</span><span style="font-family:Calibri">NS2/1030s</span>　<span style="font-family:Calibri">Phase</span>　</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">1</span></span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:SimSun">Δ</span><span style="font-family:Calibri">NS2/1313/</span><span style="font-family:SimSun">Δ</span><span style="font-family:Calibri">l1314L</span>　 <span style="font-family:Calibri">Phase 2</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px"><span style="font-family:Calibri">Nucleic acid</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">核酸疫苗</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">mRNA-1345 (PreF)</span>　<span style="font-family:Calibri">Phase 1 (P)</span>　<span style="font-family:Calibri">Phase 2</span><span style="font-family:SimSun">–</span><span style="font-family:Calibri">3 (O)</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px"><span style="font-family:Calibri">Particle based</span></span></strong><strong><span style="font-family: Shaker2Lancet-Bold;line-height: 200%;color: #0000FF;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Shaker2Lancet-Bold">基于颗粒的疫苗</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RSV F</span>　<span style="font-family:Calibri">nanoparticle</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">IVX-121</span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">V306 VLP</span>　<span style="font-family:Calibri">Phase 1</span></span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 24px">（未完待续）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px">参考文献：</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">Natalie I Mazur,</span></em><em>　</em><em><span style="font-family: Shaker2Lancet-Italic;color: #006F3C;letter-spacing: 0;font-size: 20px">et al., </span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape, </span></strong><em><span style="font-family: Shaker2Lancet-Bold;color: #FF0000;letter-spacing: 0;font-size: 20px">Lancet Infect Dis</span></em><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px"><span style="font-family:Shaker2Lancet-Bold">，</span> Published online August 8, 2022， </span></strong><span style="font-family: Tahoma;color: #505050;letter-spacing: 0;font-size: 20px">DOI: </span><a href="https://doi.org/10.1016/S1473-3099(22)00291-2" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 20px">https://doi.org/10.1016/S1473-3099(22)00291-2</span></a><span style="font-family: SimSun;color: #333333;letter-spacing: 0;font-size: 20px">，</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext" target="_blank"><span style="font-family: Shaker2Lancet-Bold;color: #6666CC;letter-spacing: 0;font-size: 20px">https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00291-2/fulltext</span></a><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 20px">.</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;line-height:28px;background:rgb(255,255,255)"><strong><span style="font-family: Shaker2Lancet-Bold;color: #231F20;letter-spacing: 0;font-size: 24px">相关博文：</span></strong><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"></a></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350903" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951408" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（１）</span></span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 20px"> 2022-08-12</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1350986" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951407" title alt="image.png" referrerpolicy="no-referrer"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>2）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-13</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351276" target="_blank"></a><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=951406" title alt="image.png" referrerpolicy="no-referrer"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351276" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>3）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-15</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351490" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>4）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-17</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:0;padding:0 0 0 0 ;background:rgb(255,255,255)"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1351871" target="_blank"><span style="font-family: Tahoma;color: #6666CC;letter-spacing: 0;font-size: 19px"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>5）</span></a><span style="font-family: Tahoma;color: #666666;letter-spacing: 0;font-size: 19px"> 2022-08-20</span></p><p style="line-height: 200%;"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1352158" target="_blank"><strong><span style="font-family: Tahoma;line-height: 200%;color: #6666CC;letter-spacing: 0;font-size: 19px;background: #FFFFFF"><span style="font-family:Tahoma">呼吸道合胞病毒疫苗和单抗最新研究进展（</span>6）</span></strong></a><span style="font-family: Tahoma;line-height: 200%;color: #666666;letter-spacing: 0;font-size: 19px;background: #FFFFFF"> 2022-08-22</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-347754-1352448.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-347754-1352448.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1352158.html" target="_black">呼吸道合胞病毒疫苗和单抗最新研究进展（6）</a><br>                    <!--大赛结束-->
                                        
  
</div>
            